Park Medi World Shares Rise on 550-Bed Uttar Pradesh Hospital Plan

Post

Shares of Park Medi World Ltd captured investor attention during Wednesday's trading session, opening in positive territory at Rs 282.75 on the Bombay Stock Exchange (BSE)—up from its previous close of Rs 282.10—despite a broader market downturn. While benchmark indices Sensex and Nifty tumbled sharply due to escalating geopolitical tensions in West Asia driving crude oil prices toward the USD 100-per-barrel mark, alongside persistent foreign fund outflows, Park Medi World counter-trended the weakness. The stock touched an intraday high of Rs 284.05, bringing the company's total market capitalization to Rs 12,193.41 crore.

Establishing Park Medicity Prayagraj Limited Under the Public-Private Partnership Model

To spearhead its ambitious healthcare infrastructure expansion, Park Medi World has officially incorporated a wholly owned subsidiary named Park Medicity Prayagraj Limited. The parent company acquired a 100 percent stake in the new entity for Rs 0.15 crore, comprising 1.5 lakh equity shares valued at Rs 10 each. This specialized subsidiary has been established to construct and operate a state-of-the-art 550-bed multi-super-speciality hospital in Uttar Pradesh, executed through a collaborative Public-Private Partnership (PPP) model with state authorities.

Comprehensive Project Details, Financial Outlay, and Future Expansion Headroom

Financial disclosures indicate that the total estimated cost of the hospital project stands at approximately Rs 200 crore, which will be funded entirely through internal accruals. Furthermore, the project benefits from a substantial financial concession of Rs 76.52 crore provided by the state government. The healthcare facility will be developed on a 3.22-acre land parcel allotted directly by the Municipal Corporation. Notably, the agreement includes an option to secure an additional 2.47 acres starting from the fifth year following the Commercial Operations Date (COD), ensuring built-in physical capacity for future multi-phase expansion.

Impressive Long-Term Share Price Performance and Historical Returns

Market analysts point out that Park Medi World's resilient trading performance aligns with its robust long-term fundamental momentum. According to BSE Analytics, the healthcare stock has delivered an impressive 88.51 per cent return year-to-date (YTD), significantly outperforming benchmark indices which have experienced a 12 per cent dip over the same period. Over a six-month horizon, the counter has gained 40.20 per cent, showcasing sustained investor confidence in the company's strategic growth initiatives and expanding hospital network.